Cathay Biotech Inc (688065.SS) stock: key figures, P/E, revenue and dividend

Materials · Commodity Chemicals · China · ISIN CNE100004447

Price
37.28 CNY
Market cap
26.89 bn CNY
P/E (2025)
44.92
P/S (2025)
8.16
Dividend yield
1.21 %
Net margin
17.17 %
Return on equity (ROE)
–
Return on assets (ROA)
2.37 %

Cathay Biotech Inc financials

Fiscal year20242025
Revenue2.96 bn CNY3.30 bn CNY
Gross profit836.44 m CNY635.09 m CNY
Operating income551.56 m CNY635.09 m CNY
EBIT581.49 m CNY631.50 m CNY
Net income488.96 m CNY565.72 m CNY
Diluted EPS – continuing operations0.84 CNY0.83 CNY

Full history since 2016, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Cathay Biotech Inc

Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing. The company's products are used in textiles, pharmaceuticals, automobiles, electronic appliances, consumer goods, engineering materials, and other industries. It exports its products. The company was incorporated in 2000 and is headquartered in Shanghai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.